Monday, April 12, 2010

StockProfiler.US: Penny Stocks in the News: Pervasip Corp. & Ohr Pharmaceutical Inc.



WHITE PLAINS, N.Y., April 12, 2010 -- Pervasip Corp. (OTCBB: PVSP), a provider of Voice over Internet Protocol (VoIP), today announced its intent to enter the smartphone applications arena.

Pervasip Corp. closed at $0.065 Friday, trading 31,500 shares.

Pervasip Corp. Enters the Smart Phone Applications Arena

About Pervasip

Pervasip Corp. delivers wholesale voice over IP (VoIP) telephone services for the residential and small business markets through its wholly owned subsidiary, VoX Communications. Leveraging a nationwide VoIP network and internally developed proprietary software and product features, VoX offers a private-label digital voice program for cable operators, cell phone carriers, WiMax carriers, CLECs, ISPs and resellers. VoX differentiates itself through a unique combination of high quality voice services, flexible back-office capabilities and automated provisioning systems. Vox recently entered the mobile VoIP services and applications arena, which is expected to approach 300 Million users by 2013. It offers a feature-rich, low-cost, high-quality alternative to traditional phone services. For more information, please visit voxcorp.net.

For additional
penny stock news, tools and tips visit http://stockprofiler.us/?action=main.market_news

-------------------------------------------

NEW YORK, NY, April 12, 2010 -- Ohr Pharmaceutical Inc. (
OTCBB: OHRP) announced today that Dr. Irach B. Taraporewala, B.S., M.S., Ph.D., a veteran healthcare executive with lengthy experience in drug development and regulatory strategy, was named Chief Executive Officer, effective immediately.

Ohr Pharmaceutical Inc. closed at $0.00 Friday, trading 0 shares.

Ohr Pharmaceutical Bolsters Senior Management Team

About Ohr Pharmaceutical Inc.

Ohr Pharmaceutical Inc. (ohrpharmaceutical.com) (
OTCBB: OHRP) is a pharmaceutical company dedicated to the development of first in class drugs for underserved therapeutic needs. Currently, Ohr is focused on the development of two drugs from its pipeline of candidate therapeutics, OHR/AVR118 for the treatment of Cachexia and EVIZON™ for the treatment of wet-AMD.

For additional
penny stock news, tools and tips visit http://stockprofiler.us/?action=main.market_news

-------------------------------------------

StockProfiler.US Announcement!

Membership with access to enhanced
stock investing tools is now FREE! Claim yours at http://stockprofiler.us/index.php?action=main.register

Stay connected with StockProfiler.US – Fan up with us on Facebook (keyword: StockProfiler.US) or follow us on Twitter at
http://twitter.com/StockProfilerUS

View free
penny stock company videos and product reviews at our YouTube channel. Visit http://www.youtube.com/StockProfilerUS

-------------------------------------------

About StockProfiler.US:

StockProfiler.US is a media source for publicly traded
penny stock companies and investors to come together and discover market opportunities. Public companies can effectively broadcast their message to a targeted audience who come to StockProfiler.US seeking an advantage by discovering companies in their startup phase or ones who have yet to be discovered by the investment community.

Call us at (603) 424-4420 or email
info@stockprofiler.us

-------------------------------------------

Please Note: All news contained herein has been previously issued by the companies mentioned in this release, and is the property of each company, respectively. All news is edited for content. The companies that are discussed in this opinion have not approved the statements made in this opinion.

This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities.

Stock Profiler.US, LLC's News Division includes but is not limited to:
http://www.stockprofiler.us, http://www.associatesfortune.com, http://www.fastmoneytalk.com, http://www.markettelegraph.com, http://www.thewallstreetleader.com, and http://www.daytradersdigest.com.

Stock Profiler.US, LLC has been compensated for services rendered; Stock Profiler.US, LLC is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter.

To view full disclaimers and terms of use, go to
http://stockprofiler.us/?action=main.disclaimer

-------------------------------------------

Keywords: penny stock, penny stock news, penny stock alerts, penny stock updates, penny stock news updates, penny stock profile

No comments:

Post a Comment